Results 201 to 210 of about 153,475 (357)

An Evaluation of the Drug Interaction Potential of Encorafenib in Combination With Binimetinib Using the Inje Cocktail in Patients With Cancer

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
A clinical drug–drug interaction (DDI) study was designed to evaluate the effect of single and multiple oral doses of encorafenib on the single oral dose pharmacokinetics (PK) of the cytochrome P450 (CYP) enzyme probe substrates, losartan (CYP2C9), midazolam (CYP3A4), caffeine (CYP1A2), omeprazole (CYP2C19), and dextromethorphan (CYP2D6) administered ...
Joseph Piscitelli   +6 more
wiley   +1 more source

Expression of claudin 1, 4 and 7 in thyroid neoplasms

open access: diamond, 2017
Dinç Süren   +9 more
openalex   +2 more sources

Does Radioiodine Therapy in Patients with Differentiated Thyroid Cancer Increase the Frequency of Another Malignant Neoplasm? [PDF]

open access: diamond, 2011
Renata M. Hirosawa   +9 more
openalex   +1 more source

Performance of Two‐Tiered Subclassification of Atypia of Undetermined Significance in Thyroid Fine‐Needle Aspiration Without Routine Molecular Testing

open access: yesDiagnostic Cytopathology, EarlyView.
ABSTRACT Background The third edition of the Bethesda system for reporting thyroid cytopathology recommends a simplified two‐tiered subclassification of atypia of undetermined significance (AUS), dividing cases into AUS with nuclear atypia (AUS‐Nuclear) and other atypia (AUS‐Other).
Pocholo D. Santos   +2 more
wiley   +1 more source

Variation in the Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features.

open access: yesJ Clin Endocrinol Metab, 2022
Chen DW   +5 more
europepmc   +1 more source

Pitfalls in the Diagnosis of Thyroid Neoplasms

open access: yesPathology - Research and Practice, 1987
J, Rosai, M L, Carcangiu
openaire   +2 more sources

Home - About - Disclaimer - Privacy